Menu Search
Equities

As One Corp

  • Add to watchlist
  • Add to portfolio
  • Add an alert
IUSDF:PKL

As One Corp

Actions
Health CareMedical Equipment and Services
  • Price (USD)46.28
  • Today's Change0.00 / 0.00%
  • Shares traded53.00
  • 1 Year change--
  • Beta1.0605
Data delayed at least 15 minutes, as of Aug 31 2022 15:30 BST.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

As One Corp is a Japan-based company principally engaged in the sale of scientific equipment and apparatus for various laboratories, research institutes, production facilities and medical facilities. The research and industrial equipment business is engaged in the wholesale of equipment and apparatus, which is used by researchers and technicians, to scientific equipment dealers. This business is also engaged in the provision of product catalogs to dealers, as well as the import and sale of physics and chemistry equipment. The hospital and nursing care business is engaged in the wholesale of equipment and apparatus, which is used by nursing care-related persons, to medical and nursing care institutions. The other business provides purchasing business proxy service using a web system, and to receive the system usage fee by the final user who participates in the system.

  • Revenue in JPY (TTM)107.58bn
  • Net income in JPY8.97bn
  • Incorporated1962
  • Employees731.00
  • Location
    As One Corp2-1-27, Edobori, Nishi-kuOSAKA-SHI 550-8527JapanJPN
  • Phone+81 664471210
  • Fax+81 664471225
  • Websitehttps://www.as-1.co.jp/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.